Preparation of and formulation comprising a MEK inhibitor
US9382212B1 · kind B1 · utility
7Cited by
2References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 18, 2015 |
| Grant date | Jul 5, 2016 |
| Priority date | — |
| Expiry date | Dec 18, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, processes for preparing crystallized 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, and intermediates useful therefore. Also provided herein are pharmaceutical compositions comprising this crystallized compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.